Cargando…

Roles of PDE1 in Pathological Cardiac Remodeling and Dysfunction

Pathological cardiac hypertrophy and dysfunction is a response to various stress stimuli and can result in reduced cardiac output and heart failure. Cyclic nucleotide signaling regulates several cardiac functions including contractility, remodeling, and fibrosis. Cyclic nucleotide phosphodiesterases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Si, Knight, Walter E., Yan, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023290/ https://www.ncbi.nlm.nih.gov/pubmed/29690591 http://dx.doi.org/10.3390/jcdd5020022

Ejemplares similares

Functions of PDE3 Isoforms in Cardiac Muscle
por: Movsesian, Matthew, et al.
Publicado: (2018)

The Role and Molecular Mechanism of Non-Coding RNAs in Pathological Cardiac Remodeling
por: Gao, Jinning, et al.
Publicado: (2017)

Role of resveratrol in inhibiting pathological cardiac remodeling
por: Fan, Shaowei, et al.
Publicado: (2022)

Strain Imaging for the Early Detection of Cardiac Remodeling and Dysfunction in Primary Aldosteronism
por: Chen, Yilin, et al.
Publicado: (2022)

Molecular targets for PDE inhibitor-mediated improvement of cardiac dysfunction in the mdx mouse?
por: Adamo, Candace M, et al.
Publicado: (2011)

Metabolic Coordination of Physiological and Pathological Cardiac Remodeling
por: Gibb, Andrew A., et al.
Publicado: (2018)

Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions
por: Szczypka, Marianna
Publicado: (2020)

Novel Protective Role of Myeloid Differentiation 1 in Pathological Cardiac Remodelling
por: Xiong, Xiaojv, et al.
Publicado: (2017)

Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling
por: Sato, Teruki, et al.
Publicado: (2019)

The Roles of Noncardiomyocytes in Cardiac Remodeling
por: Yang, Dan, et al.
Publicado: (2020)

Targeted disruption of the heat shock protein 20–phosphodiesterase 4D (PDE4D) interaction protects against pathological cardiac remodelling in a mouse model of hypertrophy
por: Martin, Tamara P., et al.
Publicado: (2014)

Increased Cardiac Myocyte PDE5 Levels in Human and Murine Pressure Overload Hypertrophy Contribute to Adverse LV Remodeling
por: Vandenwijngaert, Sara, et al.
Publicado: (2013)

Activation of PDE10 and PDE11
por: Jäger, Ronald, et al.
Publicado: (2011)

Differential effects of PDE5 inhibitors on cardiac dysfunction in the MDX ouse model of Duchenne muscular dystrophy
por: Rybalkin, Sergei D, et al.
Publicado: (2013)

Effects of PDE type 5 inhibitors on Left Ventricular Diastolic Dysfunction in Resistant Hypertension
por: de Faria, Ana Paula Cabral, et al.
Publicado: (2015)

Ultrasound‐targeted microbubble destruction mediates PDE5i/NO integration for cavernosum remodeling and penile rehabilitation
por: Yang, Wende, et al.
Publicado: (2023)

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
por: Wu, Moxin, et al.
Publicado: (2021)

Cardiac Fibrosis: Key Role of Integrins in Cardiac Homeostasis and Remodeling
por: Meagher, Patrick B., et al.
Publicado: (2021)

The Role of Epoxyeicosatrienoic Acids in Cardiac Remodeling
por: Lai, Jinsheng, et al.
Publicado: (2021)

Burn-Induced Cardiac Mitochondrial Dysfunction via Interruption of the PDE5A-cGMP-PKG Pathway
por: Wen, Jake J., et al.
Publicado: (2020)

High Dietary Phosphate Exacerbates and Acts Independently of Low Autophagy Activity in Pathological Cardiac Remodeling and Dysfunction
por: Shi, Mingjun, et al.
Publicado: (2021)

Imaging of PDE2- and PDE3-Mediated cGMP-to-cAMP Cross-Talk in Cardiomyocytes
por: Pavlaki, Nikoleta, et al.
Publicado: (2018)

Sotagliflozin attenuates cardiac dysfunction and remodeling in myocardial infarction rats
por: Zhong, Peng, et al.
Publicado: (2023)

The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure
por: Song, Weihua, et al.
Publicado: (2015)

PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking
por: Lugnier, Claire, et al.
Publicado: (2021)

Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation
por: Chen, Jianmin, et al.
Publicado: (2021)

STING protects against cardiac dysfunction and remodelling by blocking autophagy
por: Xiong, Rui, et al.
Publicado: (2021)

Role of CCR2-Positive Macrophages in Pathological Ventricular Remodelling
por: Yerra, Veera Ganesh, et al.
Publicado: (2022)

Nonalcoholic steatohepatitis (NASH) is associated with cardiac remodeling and dysfunction
por: Simon, Tracey G., et al.
Publicado: (2017)

Evaluation of PDE4 inhibition for COPD
por: Wang, Desuo, et al.
Publicado: (2006)

Treating COPD with PDE 4 inhibitors
por: Brown, William M
Publicado: (2007)

Midkine’s Role in Cardiac Pathology
por: Woulfe, Kathleen C., et al.
Publicado: (2017)

Cryptotanshinone Attenuated Pathological Cardiac Remodeling In Vivo and In Vitro Experiments
por: Li, Wen-jing, et al.
Publicado: (2023)

Long Noncoding RNAs in Pathological Cardiac Remodeling: A Review of the Update Literature
por: Zhou, Huan, et al.
Publicado: (2019)

Intracavernosal injections in the diagnosis and treatment of PDE–5 resistant erectile dysfunction
por: Jakubczyk, Tomasz
Publicado: (2013)

AB233. PDE5-Is for erectile dysfunction in patients with multiple sclerosis
por: Yang, Xingliang, et al.
Publicado: (2016)

Dr. Bang-Ping Jiann: PDE5 inhibitors in erectile dysfunction
por: Gao, Lucine M.
Publicado: (2016)

Role of TGF-β on cardiac structural and electrical remodeling
por: Ramos-Mondragón, Roberto, et al.
Publicado: (2008)

The Role of Lysyl Oxidase Enzymes in Cardiac Function and Remodeling
por: Rodríguez, Cristina, et al.
Publicado: (2019)

Urocortin Role in Ischemia Cardioprotection and the Adverse Cardiac Remodeling
por: Calderón-Sánchez, Eva M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bh60vfh8kjsr6hje62n2itdk9a